Fortress Biotech
FBIO
85 hedge funds and large institutions have $110M invested in Fortress Biotech in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.
0.71% less ownership
Funds ownership: 34.09% → 33.37% (-0.71%)
4% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 28
2% less funds holding
Funds holding: 87 → 85 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
27% less capital inflows, than outflows
Capital inflows: $6.14M | Capital outflows: $8.36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.16M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$894K |
| 3 |
BlackRock
New York
|
+$516K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$481K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$479K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.32M |
| 2 |
Two Sigma Investments
New York
|
-$1.68M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$775K |
| 4 |
6CM
683 Capital Management
New York
|
-$635K |
| 5 |
SC
Sepio Capital
Salt Lake City,
Utah
|
-$427K |
FBIO Hedge Fund Activity: Q1 2021 in Review
85 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2021, worth a combined $110M — up 9.1% from $101M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FBIO and 7 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 27 added.
The largest buyer was Vanguard Group, adding an estimated $2.16M. The largest seller was Millennium Management, cutting an estimated $2.32M.
- 85 institutional investors held Fortress Biotech (FBIO) as of Q1 2021, down from 87 in Q4 2020.
- Funds reported $110M of Fortress Biotech stock for Q1 2021, up 9.1% quarter-over-quarter.
- 7 funds opened new Fortress Biotech positions in Q1 2021 and 9 closed out, a net change of -2 holders.
- The largest Fortress Biotech buyer in Q1 2021 was Vanguard Group, an estimated $2.16M added.
- The largest Fortress Biotech seller in Q1 2021 was Millennium Management, an estimated $2.32M sold.
Based on aggregated 13F filings for Q1 2021.